Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chloé Laurencin

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
La Revue Du Praticien|March 15, 2019
[Parkinson's disease treatment: from honey moon to motor fluctuations]Chloé Laurencin, Teodor Danaila, Stéphane Thobois
Presse Medicale (Paris, France : 1983)|January 2, 2017
Stéphane Prange, Marc Hermier, Teodor Danaila, et al.
Journal of Neurology|September 15, 2016
High incidence of carpal tunnel syndrome after deep brain stimulation in Parkinson's diseaseMarine Loizon, Chloé Laurencin, Christophe Vial, et al.
Drugs & Aging|June 15, 2022
Depression in Patients with Parkinson's Disease: Current Understanding of its Neurobiology and Implications for TreatmentStéphane Prange, Hélène Klinger, Chloé Laurencin, et al.
Neurophysiologie Clinique = Clinical Neurophysiology|November 19, 2016
Not everything that shakes is a seizure… Role of continuous EEG in the intensive care unitThomas Ritzenthaler, Chloé Laurencin, Nathalie André Obadia, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|September 30, 2015
Early Illustrations of Geste Antagoniste in Cervical and Generalized DystoniaEmmanuel Broussolle, Chloé Laurencin, Emilien Bernard, et al.
Neuroscience and Biobehavioral Reviews|January 15, 2019
Functional imaging studies of Impulse Control Disorders in Parkinson's disease need a stronger neurocognitive footingGarance M Meyer, Charlotte Spay, Chloé Laurencin, et al.
Cells|September 9, 2022
Noradrenaline and Movement Initiation Disorders in Parkinson's Disease: A Pharmacological Functional MRI Study with ClonidineMarion Criaud, Chloé Laurencin, Alice Poisson, et al.
Biomolecules|May 27, 2023
Distribution of α<sub>2</sub>-Adrenergic Receptors in the Living Human Brain Using [<sup>11</sup>C]yohimbine PETChloé Laurencin, Sophie Lancelot, Inès Merida, et al.
European Journal of Human Genetics : EJHG|June 27, 2025
Homozygous COQ9 mutation: a new cause of potentially treatable hereditary spastic paraplegiaFanny Fontaine, Audrey Labalme, Chloé Laurencin, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
La Revue Du Praticien|March 15, 2019
[Parkinson's disease treatment: from honey moon to motor fluctuations]Chloé Laurencin, Teodor Danaila, Stéphane Thobois
Presse Medicale (Paris, France : 1983)|January 2, 2017
Stéphane Prange, Marc Hermier, Teodor Danaila, et al.
Journal of Neurology|September 15, 2016
High incidence of carpal tunnel syndrome after deep brain stimulation in Parkinson's diseaseMarine Loizon, Chloé Laurencin, Christophe Vial, et al.
Drugs & Aging|June 15, 2022
Depression in Patients with Parkinson's Disease: Current Understanding of its Neurobiology and Implications for TreatmentStéphane Prange, Hélène Klinger, Chloé Laurencin, et al.
Neurophysiologie Clinique = Clinical Neurophysiology|November 19, 2016
Not everything that shakes is a seizure… Role of continuous EEG in the intensive care unitThomas Ritzenthaler, Chloé Laurencin, Nathalie André Obadia, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|September 30, 2015
Early Illustrations of Geste Antagoniste in Cervical and Generalized DystoniaEmmanuel Broussolle, Chloé Laurencin, Emilien Bernard, et al.
Neuroscience and Biobehavioral Reviews|January 15, 2019
Functional imaging studies of Impulse Control Disorders in Parkinson's disease need a stronger neurocognitive footingGarance M Meyer, Charlotte Spay, Chloé Laurencin, et al.
Cells|September 9, 2022
Noradrenaline and Movement Initiation Disorders in Parkinson's Disease: A Pharmacological Functional MRI Study with ClonidineMarion Criaud, Chloé Laurencin, Alice Poisson, et al.
Biomolecules|May 27, 2023
Distribution of α<sub>2</sub>-Adrenergic Receptors in the Living Human Brain Using [<sup>11</sup>C]yohimbine PETChloé Laurencin, Sophie Lancelot, Inès Merida, et al.
European Journal of Human Genetics : EJHG|June 27, 2025
Homozygous COQ9 mutation: a new cause of potentially treatable hereditary spastic paraplegiaFanny Fontaine, Audrey Labalme, Chloé Laurencin, et al.
Pageof 5